GE HealthCare Adds Real-Time AI Guidance to Venue Family Ultrasound Systems
Geared to clinicians who may lack ultrasound expertise, the artificial intelligence (AI)-powered Caption Guidance technology reportedly provides stepwise instruction for acquiring optimal cardiac ultrasound images.
GE HealthCare says the addition of artificial intelligence (AI)-driven Caption Guidance technology to its Venue line of point-of-care ultrasound devices may help mitigate training and skill barriers with ultrasound use, and possibly expand the use of cardiac ultrasound for timely assessment in at-risk patients.
The Caption Guidance, a new add-on feature for the Venue line of ultrasound systems, reportedly utilizes AI to provide step-by-step guidance on how to acquire high-quality cardiac ultrasound images.
Expanding ultrasound access to clinicians who may have training and skill challenges with ultrasound may facilitate earlier point-of-care detection of heart disease in settings such as critical care wards and emergency departments, according to GE HealthCare.
“Venue Family ultrasound systems support clinical decision-making at the point of care, including the emergency department, offering simple, fast, and precise solutions. With the integration of Caption Guidance AI-driven software, these devices can enhance cardiac care and reduce the burden on sonographers and radiology departments by giving more clinicians the ability to perform scans and triage patients,” said Dietmar Seifriedsberger, the global general manager of Point of Care and Handheld Ultrasound at GE HealthCare.
Emerging AI Software for Prostate MRI Offers 95 Percent Sensitivity for csPCa
February 28th 2025In a multicenter study involving over 1,000 patients, a deep learning software offered comparable sensitivity and specificity for Gleason grade group > 2 tumors in comparison to radiologist interpretation.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can CT-Based AI Help Predict Renal Function Decline After Radioligand Therapy for mCRPC?
February 25th 2025In patients who had at least four cycles of 177Lu-PSMA-I&T for mCRPC, new research shows that a 10 percent or greater decrease in total kidney volume on CT at six months has a 90 percent AUC for predicting estimated glomerular filtration rates (eGFRs) of 30 percent or greater at one year.
